Abstract
Introduction: Although transcatheter mitral valve repair (TMVr) is a contrast-free procedure, prior single-center studies have demonstrated a high incidence of acute kidney injury (AKI) following TMVr. The main objective of this study was to examine risk factors for AKI, and its association with outcomes in patients undergoing TMVr. Methods: We queried the National Readmission Database to identify TMVr procedures performed between January 2014 and December 2017. Complex samples multivariable logistic and linear regression models were used to identify risk factors associated with AKI, as well as to determine the association between AKI and clinical outcomes (in-hospital mortality, index length of stay (LOS), 30-day all-cause readmissions, and 30-day heart failure [HF] readmissions). Results: Of 14,623 patients who underwent TMVr during the study period, 2,001 (13.6%) had a diagnosis of AKI. HF, chronic kidney disease, chronic liver disease, fluid/electrolyte disorder, weight loss, nonelective admission, cardiogenic shock, and bleeding/transfusion were independently associated with an increased risk of AKI. In patients undergoing TMVr, AKI was associated with an increased risk of in-hospital mortality (adjusted odds ratio [aOR], 4.94; 95% confidence interval [CI], 2.92–8.34), 30-day all-cause readmissions (aOR, 1.91; 95% CI, 1.49–2.46), 30-day HF readmissions (aOR, 2.30; 95% CI, 1.38–3.84), and longer index LOS (adjusted parameter estimate, 5.78; 95% CI, 5.26–6.41). Conclusion: AKI in the setting of TMVr is common and is associated with worse clinical outcomes. Further studies are needed to determine if optimizing renal function prior to TMVr may improve outcomes, as well as to understand the impact of TMVr itself on renal function.
References
1.
Tsai
TT
, Patel
UD
, Chang
TI
, Kennedy
KF
, Masoudi
FA
, Matheny
ME
, et al Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry
. JACC Cardiovasc Interv
. 2014 Jan
;7
(1
):1
–9
. .2.
Sinning
J-M
, Ghanem
A
, Steinhäuser
H
, Adenauer
V
, Hammerstingl
C
, Nickenig
G
, et al Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation
. JACC Cardiovasc Interv
. 2010 Nov
;3
(3
):1141
–9
. .3.
Rosner
MH
, Okusa
MD
. Acute kidney injury associated with cardiac surgery
. Clin J Am Soc Nephrol
. 2006 Jan
;1
(1
):19
–32
. .4.
James
MT
, Ghali
WA
, Knudtson
ML
, Ravani
P
, Tonelli
M
, Faris
P
, et al Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography
. Circulation
. 2011 Feb 1
;123
(123
):409
–16
. .5.
Feldman
T
, Foster
E
, Glower
DD
, Glower
DG
, Kar
S
, Rinaldi
MJ
, et al Percutaneous repair or surgery for mitral regurgitation
. N Engl J Med
. 2011 Apr 14
;364
(15
):1395
–406
. .6.
Stone
GW
, Lindenfeld
J
, Abraham
WT
, Kar
S
, Lim
DS
, Mishell
JM
, et al Transcatheter mitral-valve repair in patients with heart failure
. N Engl J Med
. 2018 Dec 13
;379
(379
):2307
–18
. .7.
Obadia
J-F
, Messika-Zeitoun
D
, Leurent
G
, Iung
B
, Bonnet
G
, Piriou
N
, et al Percutaneous repair or medical treatment for secondary mitral regurgitation
. N Engl J Med
. 2018 Dec 13
;379
(379
):2297
–306
. .8.
Körber
MI
, Scherner
M
, Kuhr
K
, Kasisada
H
, Ney
S
, Pfister
R
, et al Acute kidney injury following percutaneous edge-to-edge vs. minimally invasive surgical mitral valve repair: incidence, predictors and prognostic value
. EuroIntervention
. 2018 Feb 20
;13
(13
):1645
–51
. .9.
HCUP-US Home Page [Internet]. [cited 2020 Apr 18]. Available from: https://www.hcup-us.ahrq.gov/.
10.
Waikar
SS
, Wald
R
, Chertow
GM
, Curhan
GC
, Winkelmayer
WC
, Liangos
O
, et al Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure
. J Am Soc Nephrol
. 2006 Jun
;17
(6
):1688
–94
. .11.
Tomlinson
LA
, Riding
AM
, Payne
RA
, Abel
GA
, Tomson
CR
, Wilkinson
IB
, et al The accuracy of diagnostic coding for acute kidney injury in England: a single centre study
. BMC Nephrol
. 2013 Mar 13
;14
(14
):58
. .12.
HCUP-US Methods Series [Internet]. [cited 2020 Apr 18]. Available from: https://www.hcup-us.ahrq.gov/reports/methods/methods.jsp.
13.
Spieker
M
, Hellhammer
K
, Katsianos
S
, Wiora
J
, Zeus
T
, Horn
P
, et al Effect of acute kidney injury after percutaneous mitral valve repair on outcome
. Am J Cardiol
. 2018 Jul 15
;122
(122
):316
–22
. .14.
Taramasso
M
, Latib
A
, Denti
P
, Candreva
A
, Buzzatti
N
, Giannini
F
, et al Acute kidney injury following MitraClip implantation in high risk patients: incidence, predictive factors and prognostic value
. Int J Cardiol
. 2013 Oct 30
;169
(2
):e24
–5
. .15.
Liao
YB
, Deng
XX
, Meng
Y
, Zhao
ZG
, Xiong
TY
, Meng
XJ
, et al Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis
. EuroIntervention
. 2017 Apr 20
;12
(12
):2067
–74
. .16.
Najjar
M
, Salna
M
, George
I
. Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes
. Expert Rev Cardiovasc Ther
. 2015 Mar
;13
(3
):301
–16
. .17.
Tirado-Conte
G
, Rodés-Cabau
J
, Rodríguez-Olivares
R
, Barbanti
M
, Lhermusier
T
, Amat-Santos
I
, et al Clinical outcomes and prognosis markers of patients with liver disease undergoing transcatheter aortic valve replacement: a propensity score-matched analysis
. Circ Cardiovasc Interv
. 2018
;11
(11
):e005727
. .18.
Shah
B
, Villablanca
PA
, Vemulapalli
S
, Manandhar
P
, Amoroso
NS
, Saric
M
, et al Outcomes after transcatheter mitral valve repair in patients with renal disease
. Circ Cardiovasc Interv
. 2019
;12
(12
):e007552
. .19.
Sun
LY
, Wijeysundera
DN
, Tait
GA
, Beattie
WS
. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery
. Anesthesiology
. 2015 Sep
;123
(3
):515
–23
. .20.
Machowska
A
, Carrero
JJ
, Lindholm
B
, Stenvinkel
P
. Therapeutics targeting persistent inflammation in chronic kidney disease
. Transl Res
. 2016 Jan
;167
(167
):204
–13
. .21.
Chancharoenthana
W
, Leelahavanichkul
A
. Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?
World J Gastroenterol
. 2019 Jul 28
;25
(25
):3684
–703
. .22.
Russ
KB
, Stevens
TM
, Singal
AK
. Acute kidney injury in patients with cirrhosis
. J Clin Transl Hepatol
. 2015 Sep 28
;3
(3
):195
–204
. .23.
Ahuja
KR
, Nazir
S
, Saad
AM
, Isogai
T
, Gad
MM
, Kaur
M
, et al Temporal trends and outcomes following urgent/emergent transcatheter mitral valve repair in the United States
. JACC Cardiovasc Interv
. 2020 Jul 13
;13
(13
):1611
–3
. .24.
Kolte
D
, Khera
S
, Vemulapalli
S
, Dai
D
, Heo
S
, Goldsweig
AM
, et al Outcomes following urgent/emergent transcatheter aortic valve replacement: insights from the STS/ACC TVT registry
. JACC Cardiovasc Interv
. 2018 25
;11
(11
):1175
–85
. .25.
Karrowni
W
, Vora
AN
, Dai
D
, Wojdyla
D
, Dakik
H
, Rao
SV
. Blood transfusion and the risk of acute kidney injury among patients with acute coronary syndrome undergoing percutaneous coronary intervention
. Circ Cardiovasc Interv
. 2016
;9
(9
):e003279
. .26.
Ohno
Y
, Maekawa
Y
, Miyata
H
, Inoue
S
, Ishikawa
S
, Sueyoshi
K
, et al Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention
. J Am Coll Cardiol
. 2013 Oct 1
;62
(62
):1260
–6
. .27.
Ronco
C
, Haapio
M
, House
AA
, Anavekar
N
, Bellomo
R
. Cardiorenal syndrome
. J Am Coll Cardiol
. 2008 Nov 4
;52
(19
):1527
–39
. .28.
Berl
T
, Henrich
W
. Kidney-heart interactions: epidemiology, pathogenesis, and treatment
. Clin J Am Soc Nephrol
. 2006 Jan
;1
(1
):8
–18
. .29.
Lima
FV
, Kolte
D
, Rofeberg
V
, Molino
J
, Zhang
Z
, Elmariah
S
, et al Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: analysis of the 2014–2015 Nationwide readmissions databases
. Catheter Cardiovasc Interv
. 2020 Sep 1
;96
(3
):664
–74
.30.
Thakar
CV
, Parikh
PJ
, Liu
Y
. Acute kidney injury (AKI) and risk of readmissions in patients with heart failure
. Am J Cardiol
. 2012 May 15
;109
(10
):1482
–6
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
